Loading...
•
Jun 30, 2024
Alphatec Q2 2024 Earnings Report
Surgical revenue grew and drove total revenue growth, full-year revenue and profitability guidance increased.
Key Takeaways
Alphatec Holdings, Inc. reported a 25% increase in total revenue to $146 million for Q2 2024, driven by a 27% growth in surgical revenue. The company also raised its full-year revenue and profitability guidance.
Launched EOS Insight, integrating EOS imaging, automation and AI into spine operating rooms.
Expanded U.S. footprint, resulting in a record 244 surgeon training engagements.
Achieved 20% growth in new surgeon adoption.
Deployed over $50 million of revenue-generating assets.
Forward Guidance
For the full year 2024, the company expects total revenue to grow 25% to $602 million, including surgical revenue of $537 million and EOS revenue of $65 million. Non-GAAP adjusted EBITDA is expected to be approximately $25.5 million.
Positive Outlook
- Total revenue expected to grow 25% to $602 million.
- Surgical revenue projected at $537 million.
- EOS revenue anticipated at $65 million.
- Non-GAAP adjusted EBITDA expected to be approximately $25.5 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...